home · filing · 0000898432-22-000319
8-K
filed April 29, 2022, 7:59 PM ET
ticker IRMD
CIK 0001325618
leadership
confidence high
sentiment negative
materiality 0.60
iRadimed CFO/COO Resigns; Controller Named Interim CFO
IRADIMED CORP
Chris Scott, CFO and COO, resigns effective May 27, 2022 to pursue other opportunities.
Matt Garner, Controller, appointed interim CFO effective April 28, 2022.
Garner to receive $50,000 bonus (grossed up to max $76,000) upon permanent CFO appointment.
Formal search for a new CFO has commenced.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2022-05-27
Successor Matt Garner
Filed April 29, 2022, 7:59 PM ET
announcing the resignation of Chris Scott, Chief Financial and Operating Officer of iRadimed Corporation (the “Company”), effective May 27, 2022.
Effective 2022-04-28
Filed April 29, 2022, 7:59 PM ET
has appointed Matt Garner, Controller, to serve as interim Chief Financial Officer, effective April 28, 2022.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Chris Scott resigned as Chief Financial and Operating Officer at IRADIMED CORP.
Action resigned
Role Chief Financial and Operating Officer
Exact text from the filing
announcing the resignation of Chris Scott, Chief Financial and Operating Officer of iRadimed Corporation (the “Company”), effective May 27, 2022.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Matt Garner was appointed as interim Chief Financial Officer at IRADIMED CORP.
Action appointed
Role interim Chief Financial Officer
Exact text from the filing
has appointed Matt Garner, Controller, to serve as interim Chief Financial Officer, effective April 28, 2022.
View on SEC.gov
Source: SEC EDGAR
accession 0000898432-22-000319
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.